TrialJAMA oncology2023

Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Phase 2 Nonrandomized Controlled Trial.

Motoko Tachihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.